Patents by Inventor Karol Lacki

Karol Lacki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11285460
    Abstract: The invention discloses a separation matrix for purification of biological particles, comprising a plurality of particles having a porous core entity and a porous shell entity covering the core entity, wherein the core entity comprises at least 50 micromole/ml primary amines present on covalently attached ligands displaying at least two primary amines per ligand and the shell entity comprises less than 20 micromole/ml primary amines The invention further discloses a method of purifying biological particles and a method of manufacturing a separation matrix.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: March 29, 2022
    Assignee: CYTIVA BIOPROCESS R&D AB
    Inventors: Jean-Luc Maloisel, Karolina Busson, Karol Lacki, Bjorn Noren, Helena Skoglar
  • Publication number: 20210080434
    Abstract: A chromatography system with a main column comprising a chromatography resin, a first guard column and a second guard column, wherein the first guard column is connected to a first end of the main column, the second guard column is connected to a second end of the main column and the bed volumes of said first and second guard columns are each less than about 50% of the bed volume of the main column.
    Type: Application
    Filed: November 24, 2020
    Publication date: March 18, 2021
    Inventor: Karol Lacki
  • Publication number: 20200378934
    Abstract: There is provided a method and a corresponding system for determining binding capacities of a chromatography column. The method includes detecting a feed signal representative of the composition of a feed material provided to the inlet of the column. The method further includes detecting an effluent signal representative of the composition of the effluent from the column. The method further includes using the feed signal and the effluent signal to determine binding capacities of the column.
    Type: Application
    Filed: August 18, 2020
    Publication date: December 3, 2020
    Inventors: Petra Bangtsson, Erik Estrada, Karol Lacki, Helena Skoglar
  • Patent number: 10843104
    Abstract: A chromatography system for separation of a biopolymer is described, comprising at least one feed tank, at least one hold tank, at least one elution buffer tank, at least one eluate tank, at least two packed bed chromatography columns and at least one pump and at least one outlet detector both fluidically connected to said each packed bed chromatography column, wherein the feed tank, the hold tank(s), the elution buffer tank and the eluate tank are each fluidically connected to the packed bed chromatography columns via a system of valves.
    Type: Grant
    Filed: May 19, 2014
    Date of Patent: November 24, 2020
    Assignee: Cytiva Sweden AB
    Inventors: Karol Lacki, Martin Hall
  • Patent number: 10598638
    Abstract: A chromatography lab system comprising a cooling compartment arranged to hold both fraction collector devices and sample containers, whereby the cooling compartment comprises an identifying device which is arranged to identify the fraction collector devices such that fractions from the chromatography are collected only in the fraction collector devices.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: March 24, 2020
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Bjorn Olovsson, Karol Lacki, Mikael Berg
  • Publication number: 20190128859
    Abstract: A chromatography lab system comprising a cooling compartment arranged to hold both fraction collector devices and sample containers, whereby the cooling compartment comprises an identifying device which is arranged to identify the fraction collector devices such that fractions from the chromatography are collected only in the fraction collector devices.
    Type: Application
    Filed: October 30, 2018
    Publication date: May 2, 2019
    Applicant: GE Healthcare Bio-Sciences AB
    Inventors: Bjorn Olovsson, Karol Lacki, Mikael Berg
  • Patent number: 10265697
    Abstract: A micro titre plate comprising a number of wells filled with separation matrix. According to the invention the volume of the separation matrix is varied between at least some of the wells.
    Type: Grant
    Filed: October 12, 2016
    Date of Patent: April 23, 2019
    Inventor: Karol Lacki
  • Publication number: 20180340917
    Abstract: A chromatography system with a main column comprising a chromatography resin, a first guard column and a second guard column, wherein the first guard column is connected to a first end of the main column, the second guard column is connected to a second end of the main column and the bed volumes of said first and second guard columns are each less than about 50% of the bed volume of the main column.
    Type: Application
    Filed: August 6, 2018
    Publication date: November 29, 2018
    Applicant: GE Healthcare Bio-Sciences AB
    Inventor: Karol Lacki
  • Publication number: 20170056877
    Abstract: A micro titre plate comprising a number of wells filled with separation matrix. According to the invention the volume of the separation matrix is varied between at least some of the wells.
    Type: Application
    Filed: October 12, 2016
    Publication date: March 2, 2017
    Inventor: Karol Lacki
  • Patent number: 9551694
    Abstract: A micro titer plate comprising a number of wells filled with separation matrix. According to the invention the volume of the separation matrix is varied between at least some of the wells.
    Type: Grant
    Filed: October 7, 2009
    Date of Patent: January 24, 2017
    Assignee: GE Healthcare BioProcess R&D AB
    Inventor: Karol Lacki
  • Publication number: 20160367966
    Abstract: The invention discloses a separation matrix for purification of biological particles, comprising a plurality of particles having a porous core entity and a porous shell entity covering the core entity, wherein the core entity comprises at least 50 micromole/ml primary amines present on covalently attached ligands displaying at least two primary amines per ligand and the shell entity comprises less than 20 micromole/ml primary amines The invention further discloses a method of purifying biological particles and a method of manufacturing a separation matrix.
    Type: Application
    Filed: February 18, 2015
    Publication date: December 22, 2016
    Inventors: Jean-Luc Maloisel, Karolina Busson, Karol Lacki, Bjorn Noren, Helena Skoglar
  • Publication number: 20150328563
    Abstract: The invention discloses a process for chromatographic separation of at least one target biomolecule from at least one contaminant, comprising the steps of: a) providing an axial chromatography column comprising a consolidated bed of separation matrix particles, where the consolidated bed is confined between a bottom support net and a movable top adaptor; b) separating a target biomolecule from at least one contaminant on the column; c) raising the adaptor by at least 10% of the height of the consolidated bed; d) flowing a cleaning liquid upwards through the bed under conditions sufficient to liquefy the bed, and; e) repacking the matrix particles of the liquefied bed to create a consolidated bed and lowering the adaptor such that it contacts the packed bed and optionally compresses it, and; f) separating a target biomolecule from at least one contaminant on the column.
    Type: Application
    Filed: December 12, 2013
    Publication date: November 19, 2015
    Applicant: GE Healthcare Bio-Sciences AB
    Inventors: Karol Lacki, Hans J. Johansson
  • Publication number: 20140251913
    Abstract: A chromatography system for separation of a biopolymer is described, comprising at least one feed tank, at least one hold tank, at least one elution buffer tank, at least one eluate tank, at least two packed bed chromatography columns and at least one pump and at least one outlet detector both fluidically connected to said each packed bed chromatography column, wherein the feed tank, the hold tank(s), the elution buffer tank and the eluate tank are each fluidically connected to the packed bed chromatography columns via a system of valves.
    Type: Application
    Filed: May 19, 2014
    Publication date: September 11, 2014
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: KAROL LACKI, MARTIN HALL
  • Publication number: 20130248451
    Abstract: A chromatography system for separation of a biopolymer is described, comprising at least one feed tank, at least one hold tank, at least one elution buffer tank, at least one eluate tank, at least two packed bed chromatography columns and for each packed bed chromatography column at least one pump and at least one outlet detector both connected to said each packed bed chromatography column, wherein the feed tank, the hold tank(s), the elution buffer tank and the eluate tank are each connected to the packed bed chromatography columns via a system of valves.
    Type: Application
    Filed: December 2, 2011
    Publication date: September 26, 2013
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Martin Hall, Karol Lacki
  • Publication number: 20130213884
    Abstract: A chromatography system with a main column comprising a chromatography resin, a first guard column and a second guard column, wherein the first guard column is connected to a first end of the main column, the second guard column is connected to a second end of the main column and the bed volumes of said first and second guard columns are each less than about 50% of the bed volume of the main column.
    Type: Application
    Filed: October 24, 2011
    Publication date: August 22, 2013
    Applicant: GE HEALTHCARE BIO-SCIENCE AB
    Inventor: Karol Lacki
  • Patent number: 8268915
    Abstract: The present invention relates to a liquid mixture comprising a first polymer, which is a poly(acid), a second polymer, which is a poly(ether), and at least one salt, wherein the molecular weight of the poly(acid) is in the range of 1000-100,000 Da. The second polymer is selected to be capable of forming immiscible aqueous phases in the presence of the poly(acid) and salt. The poly(acid) may be selected from the group consisting of poly(acrylic acid) and poly(methacrylic acid), and the second synthetic polymer may comprise ethylene oxide. The invention may be used for separation of biomolecules, cells or particles.
    Type: Grant
    Filed: June 16, 2008
    Date of Patent: September 18, 2012
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Hans O. Johansson, James Van Alstine, Rolf Hjorth, Karol Lacki, Emmanuel Macedo, Gunnar Malmquist, Jamil Shanagar
  • Publication number: 20120091063
    Abstract: A method for determining binding capacities of a chromatography column (1; 39, 47, 59; 107, 109, 111, 113), comprising: detecting a feed signal (21; 201) representative of the composition of a feed material provided to the inlet of the column; detecting an effluent signal (23; 203, 205, 207, 209) representative of the composition of the effluent from the column; using the feed signal and the effluent signal to determine binding capacities of the column. And a method for controlling a chromatography system comprising at least one column, comprising the steps of: determining binding capacities of the at least one chromatography column according to above; and controlling the start and stop of the different chromatography process steps according to the determined binding capacities.
    Type: Application
    Filed: June 21, 2010
    Publication date: April 19, 2012
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Petra Bangtsson, Erik Estrada, Karol Lacki, Helena Skoglar
  • Publication number: 20120022239
    Abstract: The present invention relates to methods of isolating biomolecules. More particularly, the invention relates to methods for isolating antibodies (mAbs) and related proteins including antibody fragments (Fabs) under conditions where they are positive and relatively hydrophobic and will react with negatively charged polymer to form polymer-protein complexes which precipitate. The isolation can be accomplished using inexpensive and biocompatible negatively charged polymers such as polyacrylic acid or carboxymethyldextran polymers of various molecular weights as precipitant. It occurs at relatively high concentrations of polymer (e.g. 10%) and high salt concentration (>50 mM) and conductivity (e.g. >10 mS/cm) over wide range of pH.
    Type: Application
    Filed: January 11, 2010
    Publication date: January 26, 2012
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: James Van Alstine, Jamil Shanagar, Rolf Hjorth, Karol Lacki
  • Publication number: 20110257378
    Abstract: The invention relates to an aqueous two phase extraction (ATPE) augmented precipitation process, which may be used to recover and also partially purify therapeutic proteins, including monoclonal antibodies from a crude multi-component mixture. The process involves the formation of a forward extraction PEG-Phosphate ATPE system in which the target product is preferentially partitioned to the polymer rich phase. A second ATPE back extraction system is then formed by introducing the polymer rich phase from the forward extraction to a new phosphate salt rich phase, causing the product to precipitate at the interface between the two phases. This precipitate is then recovered and resolubilised in a suitable buffer and may be passed on for further purification.
    Type: Application
    Filed: November 18, 2009
    Publication date: October 20, 2011
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Richard Tran, Nigel J. Titchener-Hooker, Karol Lacki
  • Publication number: 20110195517
    Abstract: A micro titre plate comprising a number of wells filled with separation matrix. According to the invention the volume of the separation matrix is varied between at least some of the wells.
    Type: Application
    Filed: October 7, 2009
    Publication date: August 11, 2011
    Applicant: GE Healthcare Bio-Science AB
    Inventor: Karol Lacki